Buy Atea Pharmaceuticals Stock | AVIR Stock Price & Latest News | Public
AVIR

Atea Pharmaceuticals

$0.00 (0.00%)Today
    View Atea Pharmaceuticals (AVIR) stock trends here

    About AVIR

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.29
    -0.44
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.44

    Actual EPS
    Q4 2020

    Stats

    Market Cap$4,41B
    Volume10,67k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$57.19
    1 Year Low$24.15
    Open$51.86
    High$56.65
    Low$51.03

    Buy any stock with any amount of money.

    Download the App
    Download the app